Announcements Trials

Browse Landscape

Phase

Phase 2 3 Phase EARLY_PHASE1 2 Phase 3 2 Phase NA 1 Phase 2/3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Neoplasms 23 Carcinoma, Non-Small-Cell Lung 15 Prostatic Neoplasms 14 Stomach Neoplasms 12 Colorectal Neoplasms 12 Breast Neoplasms 12 Pancreatic Neoplasms 11 Leukemia, Myeloid, Acute 10 Neoplasm Metastasis 9 Lung Neoplasms 9 Hematologic Neoplasms 9 Head and Neck Neoplasms 9 Endometrial Neoplasms 9 Carcinoma, Hepatocellular 9 Squamous Cell Carcinoma of Head and Neck 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Ovarian Neoplasms 8 Myasthenia Gravis 7 Melanoma 7 Uterine Cervical Neoplasms 6 Recurrence 6 Rectal Neoplasms 6 Neoplasms by Site 6 Neoplasms by Histologic Type 6 Lymphoma 6 Leukemia 6 Urinary Bladder Neoplasms 5 Neoplasms, Plasma Cell 5 Infections 5 Colonic Neoplasms 5

Interventions

Vincristine 1 Topotecan 1 Platinum Compounds 1 Melphalan 1 Hyperthermia, Induced 1 Etoposide 1 Drug Therapy 1 Cryotherapy 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Recruiting × Retinoblastoma × Clear all

NCT04681417 2025-11-28

RETINO 2018

Institut Curie

Phase 2/3 Recruiting

Other solid neoplasm

Retinoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡